{"DataElement":{"publicId":"3907041","version":"1","preferredName":"Patient Plasma Epstein-Barr Virus DNA Clinical Trial Eligibility Criteria Status","preferredDefinition":"Presence or Absence of EBV DNA in plasma collected from a patient participating in a clinical trial","longName":"Pt_Plas_EBV_DNA_St","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3876069","version":"1","preferredName":"Patient Plasma Epstein-Barr Virus DNA Clinical Trial Eligibility Criteria","preferredDefinition":"Information related to the eligibility requirement of detectable EBV DNA prior to randomization","longName":"Pati_Plas_Epst_DNA_Clin","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3876067","version":"1","preferredName":"Plasma Epstein-Barr Virus DNA Clinical Trial Eligibility Criteria","preferredDefinition":"Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.:A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.:A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information. :Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C13356:C14204:C449:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plasma","conceptCode":"C13356","definition":"Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"DNA","conceptCode":"C449","definition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A78CC5-B198-8C80-E040-BB89AD435722","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-05","modifiedBy":"ONEDATA","dateModified":"2013-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A78CC5-B1A9-8C80-E040-BB89AD435722","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3907030","version":"1","preferredName":"Patient Plasma Epstein-Barr Virus DNA Clinical Trial Eligibility Criteria Status","preferredDefinition":"presence or absence of EBV DNA","longName":"Pt_Plas_EBV_DNA_St","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Detectable","valueDescription":"Detectable","ValueMeaning":{"publicId":"3192380","version":"1","preferredName":"Detectable","longName":"3192380","preferredDefinition":"A malignant neoplasm that is detectable but not measurable.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C6D87AC-3A8E-D773-E040-BB89AD43475F","latestVersionIndicator":"Yes","beginDate":"2011-02-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7366C84-54F0-CA98-E040-BB89AD4326BA","beginDate":"2013-09-25","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-25","modifiedBy":"ONEDATA","dateModified":"2013-09-25","deletedIndicator":"No"},{"value":"Undetectable","valueDescription":"Undetectable","ValueMeaning":{"publicId":"2581800","version":"1","preferredName":"Undetectable","longName":"2581800","preferredDefinition":"Undetectable","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C95-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-11","modifiedBy":"SHIDED","dateModified":"2006-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E7366C84-54FB-CA98-E040-BB89AD4326BA","beginDate":"2013-09-25","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-25","modifiedBy":"ONEDATA","dateModified":"2013-09-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7366C84-54DC-CA98-E040-BB89AD4326BA","latestVersionIndicator":"Yes","beginDate":"2013-09-25","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-25","modifiedBy":"SBR","dateModified":"2014-01-24","changeDescription":" Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"Pt_Plas_EBV_DNA_St","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Pre-treatment EBV DNA?","type":"Preferred Question Text","description":"Pre-treatment EBV DNA?","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Post-treatment EBV DNA?","url":null,"context":"CTEP"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E736772F-6ABE-C2BA-E040-BB89AD436D13","latestVersionIndicator":"Yes","beginDate":"2013-09-25","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-09-25","modifiedBy":"FORMBUILDER","dateModified":"2014-07-25","changeDescription":" Changed from CTEP to NRG for by script Fri Jan 24 11:30:54 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}